David C Lott
Affiliation: Johns Hopkins University
- HIV risk behaviors during pharmacologic treatment for opioid dependence: a comparison of levomethadyl acetate [corrected] buprenorphine, and methadoneDavid C Lott
Chemical Dependency Program, Linden Oaks Hospital at Edward, 825 S West St, Naperville, IL 60540, USA
J Subst Abuse Treat 31:187-94. 2006..These results demonstrate that all three medications can be highly effective in decreasing HIV risk behaviors when the dose is optimized. Reductions in sexual behaviors for the METH group are consistent with known METH side effects...
- Serotonin transporter genotype and acute subjective response to amphetamineDavid C Lott
Linden Oaks Hospital at Edward, Naperville, Illinois, USA
Am J Addict 15:327-35. 2006..The separate and combined analyses of the gene-linked polymorphic region (5-HTTLPR) and the Intron 2 VNTR suggest that these two HTT polymorphisms may contribute to acute subjective responses to d-amphetamine with a small effect...
- Effectiveness of very low-cost contingency management in a community adolescent treatment programDavid C Lott
Chemical Dependency Program, Linden Oaks Hospital at Edward, Naperville, IL 60540, USA
Drug Alcohol Depend 102:162-5. 2009..Expenses were minimal at $0.39 per patient per day. These data yield additional evidence for the feasibility and effectiveness of CM methods in community adolescent treatment programs...
- Dopamine transporter gene associated with diminished subjective response to amphetamineDavid C Lott
Department of Psychiatry, The University of Chicago, Chicago, IL 60637, USA
Neuropsychopharmacology 30:602-9. 2005..The current findings have important implications for understanding the genetic determinants of variability in stimulant response and risk of abuse...
- Personality and the subjective effects of acute amphetamine in healthy volunteersTara L White
Department of Psychiatry and Human Behavior, Center for Alcohol and Addiction Studies, Brown University, Providence, RI 02912, USA
Neuropsychopharmacology 31:1064-74. 2006..Implications for the vulnerability to psychostimulant addiction in healthy nonaddicts are discussed...